Geode Capital Management LLC Has $4.58 Million Stake in Phibro Animal Health Corporation (PAHC)

Geode Capital Management LLC increased its position in Phibro Animal Health Corporation (NASDAQ:PAHC) by 9.9% during the first quarter, Holdings Channel reports. The firm owned 162,869 shares of the company’s stock after buying an additional 14,655 shares during the period. Geode Capital Management LLC’s holdings in Phibro Animal Health Corporation were worth $4,576,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Mason Street Advisors LLC boosted its position in shares of Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock worth $122,000 after buying an additional 286 shares during the period. Victory Capital Management Inc. boosted its position in shares of Phibro Animal Health Corporation by 79.2% in the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock worth $129,000 after buying an additional 2,021 shares during the period. Louisiana State Employees Retirement System boosted its position in shares of Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock worth $211,000 after buying an additional 100 shares during the period. CAPROCK Group Inc. bought a new position in shares of Phibro Animal Health Corporation during the first quarter worth approximately $213,000. Finally, Campbell & CO Investment Adviser LLC bought a new position in shares of Phibro Animal Health Corporation during the first quarter worth approximately $228,000. 47.64% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Corporation (PAHC) remained flat at $39.75 during trading on Tuesday. 7,076 shares of the company traded hands. The stock has a market capitalization of $1.58 billion, a PE ratio of 24.69 and a beta of 1.35. The stock has a 50 day moving average price of $38.09 and a 200 day moving average price of $32.39. Phibro Animal Health Corporation has a 12-month low of $20.14 and a 12-month high of $40.25.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be issued a $0.10 dividend. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 annualized dividend and a dividend yield of 1.01%. Phibro Animal Health Corporation’s payout ratio is 24.69%.

TRADEMARK VIOLATION WARNING: This article was originally reported by [[site]] and is the property of of [[site]]. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at [[permalink]].

A number of equities analysts have commented on the company. Credit Suisse Group cut Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and lifted their price target for the stock from $29.00 to $36.00 in a research note on Friday, June 2nd. Piper Jaffray Companies set a $35.00 price target on Phibro Animal Health Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. BidaskClub cut Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Finally, Zacks Investment Research raised Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $30.50.

In other news, insider Jack Bendheim sold 32,000 shares of the stock in a transaction that occurred on Thursday, July 6th. The stock was sold at an average price of $36.49, for a total value of $1,167,680.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Bfi Co., Llc sold 48,000 shares of the stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $34.82, for a total value of $1,671,360.00. Following the completion of the sale, the insider now owns 96,000 shares in the company, valued at $3,342,720. The disclosure for this sale can be found here. Over the last quarter, insiders sold 352,000 shares of company stock worth $12,599,200. Company insiders own 48.09% of the company’s stock.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).